论文部分内容阅读
目的:探讨应用乳腺数字钼靶(钼靶)和彩色多普勒超声(彩超)联合诊断乳腺癌的新进展和临床应用的价值。方法:收集了2008～2011年近4年来的136例经病理证实的乳腺癌患者的临床资料,分析乳腺钼靶和彩超的各自影像特点、鉴别诊断各自的优势及联合诊断乳腺癌的重要意义。结果:单独运用钼靶和彩超的乳腺癌诊断符合率分别为90.44%和82.35%,而联合诊断符合率可高达94.12%(128/136)。结论:在乳腺癌的诊断过程中,钼靶和彩超均为诊断乳腺癌的首选方法,两者联合应用对提高乳腺癌诊断的敏感性、准确性均有较高价值。
Objective: To explore the value of combined application of breast digital mammography (Molybdenum target) and color Doppler ultrasound (Doppler ultrasound) in the diagnosis of breast cancer and its clinical value. Methods: The clinical data of 136 patients with pathologically confirmed breast cancer from 2008 to 2011 were collected. The features of mammography and color Doppler ultrasound were analyzed. The respective advantages of differential diagnosis and the significance of combined diagnosis of breast cancer were analyzed. Results: The coincidence rates of mammography and color Doppler ultrasound in the diagnosis of breast cancer were 90.44% and 82.35% respectively, while the coincidence rate of combined diagnosis was as high as 94.12% (128/136). Conclusion: In the diagnosis of breast cancer, molybdenum target and color Doppler ultrasound are the preferred method of diagnosis of breast cancer, the combination of the two have a higher value for improving the sensitivity and accuracy of breast cancer diagnosis.